|
TMEM167A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.358100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.606400E-02 |
| Normal-vs-Stage2 |
8.678800E-01 |
| Normal-vs-Stage3 |
3.445400E-01 |
| Normal-vs-Stage4 |
2.103600E-01 |
| Stage1-vs-Stage2 |
1.818240E-01 |
| Stage1-vs-Stage3 |
7.260400E-01 |
| Stage1-vs-Stage4 |
7.606200E-01 |
| Stage2-vs-Stage3 |
4.402800E-01 |
| Stage2-vs-Stage4 |
3.004800E-01 |
| Stage3-vs-Stage4 |
9.293000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.621620E-01 |
| Normal-vs-AfricanAmerican |
9.182400E-04 |
| Normal-vs-Asian |
4.593700E-02 |
| Caucasian-vs-AfricanAmerican |
1.148300E-02 |
| Caucasian-vs-Asian |
3.676200E-01 |
| AfricanAmerican-vs-Asian |
6.664400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.647800E-02 |
| Normal-vs-Female |
1.483160E-01 |
| Male-vs-Female |
7.286200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.523750E-02 |
| Normal-vs-Age(41-60Yrs) |
4.844100E-02 |
| Normal-vs-Age(61-80Yrs) |
3.206000E-01 |
| Normal-vs-Age(81-100Yrs) |
6.297200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.125200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.226410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.740800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.827200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.745200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.955800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.250350E-01 |
| Normal-vs-Grade 2 |
4.684000E-01 |
| Normal-vs-Grade 3 |
3.240100E-02 |
| Normal-vs-Grade 4 |
4.495800E-02 |
| Grade 1-vs-Grade 2 |
3.000200E-01 |
| Grade 1-vs-Grade 3 |
7.404400E-01 |
| Grade 1-vs-Grade 4 |
8.556600E-01 |
| Grade 2-vs-Grade 3 |
2.389600E-01 |
| Grade 2-vs-Grade 4 |
2.110800E-01 |
| Grade 3-vs-Grade 4 |
7.536400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.835000E-01 |
| Normal-vs-ccB subtype |
4.990800E-01 |
| ccA subtype-vs-ccB subtype |
8.727400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.037000E-01 |
| Normal-vs-N1 |
9.993400E-01 |
| N0-vs-N1 |
7.794800E-01 |
|
|
